pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    rademikibart
    rademikibart [INN]
    Acute Asthma Suzhou Connect Biopharmaceuticals Ltd
  • Phase 2
    radgocitabine
    radgocitabine [INN]
    Refractory Acute Myeloid Leukemia Delta-Fly Pharma Inc
  • Phase 3
    radiprodil
    radiprodil
    Unspecified Neurologic Disorders GRIN Therapeutics Inc
  • Marketed
← prev
page 211 of 231
next →
Pain89
Neurology1
radium Ra 223 dichloride
Xofigo (radium Ra 223 dichloride)
Bone Metastasis
Bayer HealthCare Pharmaceuticals Inc
  • Phase 3
    rafutrombopag
    rafutrombopag [INN]
    Thrombocytopenia Jiangsu Hengrui Pharmaceuticals Co Ltd
  • Phase 1
    ragistomig
    ragistomig [INN]
    Esophageal Cancer$NBP NovaBridge Biosciences
  • Phase 2
    raguneprocel
    raguneprocel [INN]
    Parkinson's Disease Sumitomo Chemical Co Ltd
  • Phase 3
    ralinepag XR
    ralinepag
    Pulmonary Arterial Hypertension$UTHR UNITED THERAPEUTICS Corp
  • Marketed
    raloxifene hydrochloride
    Raloxifene Hydrochloride
    Post Menopausal Osteoporosis Modavar Pharmaceuticals LLC
  • Marketed
    raltegravir potassium
    Raltegravir (raltegravir potassium)
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Lupin Ltd
  • Marketed
    ramipril
    Ramipril
    Cardiovascular Risk Factors CorePharma LLC
  • Phase 3
    ramucirumab
    Cyramza (ramucirumab)
    Adenocarcinoma Of The Gastroesophageal Junction Eli Lilly and Co
  • Marketed
    ranibizumab
    Lucentis (ranibizumab)
    Choroidal Neovascularization Genentech Inc
  • Marketed
    ranitidine hydrochloride
    Ranitidine Hydrochloride
    Systemic Mastocytosis VKT Pharma Pvt Ltd
  • Marketed
    ranolazine ER
    Ranolazine
    Chronic Stable Angina Laurus Generics Inc
  • Phase 2
    ranpirnase
    Onconase (ranpirnase)
    Genital Warts (Condylomata Acuminata) Okogen Inc
  • Phase 1
    rapaprutug
    rapaprutug [INN]
    Pulmonary Arterial Hypertension Zymedi
  • Marketed
    rasagiline
    Rasagiline
    Parkinson's Disease Heritage Pharmaceuticals Inc
  • Marketed
    rasagiline mesylate
    Rasagiline Mesylate
    Parkinson's Disease Carnegie Pharmaceuticals LLC
  • Marketed
    rasburicase
    Elitek (rasburicase)
    Hyperuricemia Sanofi-Aventis US LLC
  • Phase 1
    ratangratinib
    ratangratinib [INN]
    Bile Duct Cancer (Cholangiocarcinoma) 3D Medicines Inc
  • Marketed
    ravulizumab LA
    Ultomiris (ravulizumab)
    Delayed Graft Function (DGF) Alexion Pharmaceuticals Inc
  • Marketed
    raxibacumab
    Raxibacumab
    Anthrax$EBS Emergent BioSolutions Inc.
  • Marketed
    raxtozinameran
    Comirnaty Omicron XBB.1.5 (raxtozinameran [INN])
    Coronavirus Disease 2019 (COVID-19)$PFE PFIZER INC
  • Preclinical
    rebastinib
    rebastinib
    Facioscapulohumeral Muscular Dystrophy (FSHD) Myocea Inc
  • pre_registration
    rebisufligene etisparvovec
    rebisufligene etisparvovec
    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )$RARE Ultragenyx Pharmaceutical Inc.
  • Phase 3
    rebonuputemcel
    rebonuputemcel
    Degenerative Disc Disease DiscGenics Inc
  • Phase 3
    reboxetine
    reboxetine [INN]
    Type 1 Narcolepsy (Narcolepsy with Cataplexy)$AXSM Axsome Therapeutics, Inc.
  • Preclinical
    redaporfin
    redaporfin [INN]
    Bile Duct Cancer (Cholangiocarcinoma) Luzitin SA
  • Phase 2
    refisolone
    Salubrin-HF (refisolone)
    Premenstrual Dysphoric Disorder (PMDD)$VTGN Vistagen Therapeutics, Inc.